EMpowering the microbiome health movement

The GUT microbiome

The gut microbiome (i.e: the microorganisms present in our intestine) plays a major role in maintaining our health. In case of dysfunction, the microbiome is linked to a large number of inflammatory, metabolic, and neurological diseases. The study of the microbiome opens many perspectives for tomorrow’s medicine.

For a decade, the intestinal microbiome has generated increasing interest, as evidenced by the growing number of scientific publications associated with the intestinal microbiome.

These results pave the way to many perspectives for tomorrow’s medicine in nutrition, diagnosis, personalized care and explain the growing interest and investments in the microbiome field by health and nutrition companies as well as academics.

Unfortunately, current methods of sampling the human intestinal microbiome are limited:
  • Animal models are difficult to transpose to humans
  • Faecal analysis, most commonly used and simple to implement, does not allow a representative analysis of the in-situ microbiome
  • Endoscopy is expensive, invasive and is complex to carry out on a large scale

It is well established that the intestinal microbiome has an intimate
relationship with the other organs of the body and is linked to several
diseases as diverse as:

  • diabetes
  • obesity
  • inflammatory bowel disease
  • cancer
  • neurodegenerative diseases
  • rheumatoid arthritis
  • cardiovascular diseases
  • depression
  • autism

"A wonderful bird is the Pelican.His beak can hold more than his belly can.He can hold in his beakEnough food for a week!But I'll be darned if I know how the hellican?”
-Dixon Lanier Merritt


Our solution allows multiple sampling of the microbiome in-situ with a single oral administration, in a reliable, precise, simple to administer and non-invasive manner.

The medical device is the size of a pharmaceutical pill and allows the possibility to collect the microbiome on a large scale with precision at different locations of the intestine. In turn this new approach allows the discovery and development of solutions for diagnosis and therapy that will improve human health.

Use of medical device:
Oral intake.
Passing through the stomach.
Sampling capsules release.


The founding team is composed of managers with complementary skills in scientific research, product development and company management. The technology resulting from the scientific work of the TIMC laboratory of the University Grenoble Alpes led to the creation of a company at the beginning of 2020. The founding team is composed of four scientists and a manager of a medical technology company. Pelican Health surrounded itself with a solid ecosystem of scientific, clinical and industrial partners to support its growth.

PhD, CEO & co-founder
+33 (0)7 80 99 94 17

Arnaud MARIE
Chairman of the board, co-founder

Philippe CINQUIN
MD, PhD, co-founder
+33 (0)4 76 76 87 50

PhD, co-founder
+33 (0)4 56 52 00 95

Jean-Pierre ALCARAZ
PhD, co-founder
+33 (0)4 56 52 00 83




PELICAN HEALTH has initiated scientific, industrial and commercial collaborations with major institutes and companies.